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A 58-year-old man with hypertension, severe abdominal pain, and pulseless extremities was diagnosed with an isolated
abdominal intramural hematoma (IMH). The IMH extended from the distal descending thoracic aorta to just proximal
to the renal arteries. -Blockade treatment resolved the abdominal pain but induced progressive oliguria; decreasing
-blockade treatment increased urine output but caused return of abdominal pain. An axillobifemoral bypass allowed
distal perfusion and retrograde visceral artery perfusion while maintaining normal blood pressure. The abdominal pain
resolved, urine output increased, and the patient was discharged on day 7. Six months later the patient required an
emergent thrombectomy of the axillobifemoral graft and normal antegrade aortic flow was found. A computed
tomography scan showed resolution of the IMH. (J Vasc Surg 2005;42:149-52.)Intramural hematoma (IMH) of the aorta is a dynamic
pathological process with the potential to regress or to
progress to aneurysmal formation, overt dissection, or aor-
tic rupture.1-12 The recommended initial therapeutic ap-
proach for patients with IMH is similar to that for aortic
dissection. Disease involving the ascending aorta (type A)
should be considered for urgent surgical intervention,
whereas disease involving the descending aorta (type B) can
be treated initially with medical management5,11,12,14 in-
cluding aggressive antihypertensive therapy and (if appro-
priate) negative inotropic drugs, typically in an intensive
care unit. Surgery is considered for type B IMHwhen there
is evidence of distal malperfusion (with ischemic complica-
tions, involving the digestive tract, kidneys, spinal cord, or
lower extremities) or progressive aortic enlargement with
concern for impending rupture.5,6,8-10 Refractory hyper-
tension and pain can also be considerations for surgical
intervention.
We report a case of a type B IMH in a patient who
presented with severe abdominal and back pain and pulse-
less extremities. Because medical treatment with a -
adrenergic antagonist caused oliguria, the patient was
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distal perfusion and retrograde visceral vessel perfusion yet
maintain blood pressure at normal levels.
CASE REPORT
On November 21, 2003, a 58-year-old man was transferred
from an outside facility with a diagnosis of an abdominal aortic
aneurysm. On arrival, the patient was hypertensive (systolic blood
pressure of 175/60 mm Hg, peaking at 201/65 mm Hg) and
complaining of back and abdominal pain. His laboratory study
results were notable for a creatinine level of 1.8 mg/dL (with no
previous history of renal insufficiency) and hemoglobin of 12.5
g/dL. He related a 2-week history of lower back pain radiating to
the left flank. He had a 40 pack-year history of tobacco use, and his
cardiac status was unknown. The patient did not have palpable
pulses in either lower extremity.
An emergency contrast computed tomography scan was per-
formed, which showed the findings of an IMH extending from the
level of the inferior pulmonary vein to just above the renal arteries.
The involved aortic lumen was slit-like with minimal distal perfu-
sion (Fig 1). Because of his severe hypertension, he was started on
anti-impulse therapy with a -adrenergic antagonist, which low-
ered the blood pressure to 136/65 mm Hg. Within 8 hours of
starting the -adrenergic antagonist, progressive oliguria devel-
oped, although the abdominal and back pain had resolved. The
patient’s blood pressure was allowed to increase back toward
admission levels, however, the resumption of urine production was
concomitant with return of the abdominal and flank pain. His
creatinine level also increased to 2.7 mg/dL.
Surgical options were discussed, which included replacement
of the abdominal aorta with reimplantation of the visceral vessels.
We sought to temporarily palliate the situation by restoring distal
blood flow with a right axillobifemoral bypass. This decision was
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or other medical problems as had been transferred from an outside
hospital without medical records. Our original intention was to
subsequently perform surgical replacement of the aorta at a later
date after clinical stabilization and appropriate evaluation of cardiac
function and other medical comorbidities. The axillobifemoral
bypass was performed without complication, and by postoperative
Fig 1. A, Preoperative axial computed tomography (CT) image
of the mid descending thoracic aorta shows aortic wall thickening
(7 mm) and anterior ulceration (arrow). Overall aortic diameter is
31 mm. B, Preoperative right posterior oblique (RPO) maximum
intensity projection (MIP) CT image of the descending aorta
shows total aortic occlusion below ulcer and extensive intramural
hematoma (IMH) distally (arrows). C, Preoperative coronal MIP
CT image shows reconstitution distally with flow in bilateral renal
arteries. Note residual gastrointestinal contrast from a previous
study.day 1 his pain had resolved, he was nonoliguric, his creatinine levelhad decreased to 1.5 mg/dL, and he had palpable bilateral periph-
eral pulses in each leg. On the fifth postoperative day, the patient’s
serum creatinine level was 0.7 mg/dL, and he was discharged
home 2 days later. A magnetic resonance imaging scan just before
discharge showed perfusion of all visceral vessels. The patient
continued to do well, with a normal serum creatinine level and
bilateral palpable leg pulses at 1 and 3 months follow-up. A repeat
magnetic resonance imaging scan at 3 months follow-up showed
no change in the aortic IMH.
On May 17, 2004, the patient returned to the hospital com-
plaining of acute ischemia of the right arm and leg. The patient was
successfully treated with thrombectomy of the axillobifemoral
bypass graft; however, native aortic blood flow was found. At the
time of emergent thrombectomy, the thrombus was found to
involve the limb of the right axillary to right femoral artery graft
with thrombus extending into both the right axillary artery and the
right common femoral artery. A postoperative computed tomog-
raphy scan confirmed that the abdominal aorta was completely
healed and that the graft thrombosis was presumably secondary to
competitive flow now present in the native aorto-iliac system (Fig
2). Since discharge, the patient has been followed up at 3-month
intervals for a 2-year period. The patient has been free from
abdominal or back pain; has normal bilateral femoral, popliteal,
dorsalis pedis, and posterior tibial pulses; and has normal renal
function. Because of the long-term excellent postoperative result,
we and the patient have not considered removal of the axillo-
bifemoral bypass graft.
DISCUSSION
Intramural hematoma of the aorta represents a dynamic
process, and as such investigators have attempted to classify
this disease into subgroups that might aid in prognosis and
treatment. One classification system uses the Stanford dis-
section classification: type A for disease involving the as-
Fig 1. Continuedcending aorta, type B for involvement of the descending
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clinician regardless of whether IMH is a variant of dissec-
tion or is a separate pathologic entity. With this classifica-
tion scheme, comparison with treatment options for aortic
dissection show a similar profile, although the mortality
rates for IMH are lower.9,10 In a comparison of type B
IMH with type B dissection, Kaji et al showed actuarial
survival rates for IMH (n  53) to be higher than those
survival rates for dissection patients (n  57) followed up
for 5 years (100%, 97%, and 97% vs 83%, 79%, and 79% at 1,
Fig 2. A, Postoperative right posterior oblique maximum inten-
sity projection (MIP) computed tomography image of thoracic
and upper abdominal aorta shows resumption of aortic flow with
filling of abdominal branch vessels. Ulcer unchanged proximally.
IMH has resolved. B, Postoperative coronal MIP image shows
improved abdominal aortic flow with visibility of bilateral renal
arteries.2, and 5 years respectively, P  .009).9A meta-analysis by von Kodolitsch et al showed a
significant advantage of surgical versus medical manage-
ment for type A IMH (12% vs 24% early mortality for
surgery vs medical management; P  .012). For type B
IMH,medical management seemed to be favorable (20% vs
10% early mortality for surgery vs medical management; P
 .094), although statistical significance was not reached.8
Interestingly, a recent small prospective series has shown an
increased complication rate during medical treatment of
type B IMH. In this study, 14 patients were followed up
prospectively with the history of IMH of the descending
thoracic aorta. Ten of 14 patients developed severe compli-
cations (79%) that included dissection, aneurysm forma-
tion, and death.10 Whether this increased complication rate
of type B IMHwas caused by the small sample size (n 14)
or by the fact that IMH is not diagnosed antemortem and
thus is missed on retrospective studies remains speculative
and warrants further study.
Several investigators have attempted to define the
pathogenesis of IMH of the aorta; however, this remains a
somewhat controversial subject. Cambria, in a short review
article in 2002, suggested that IMH is typically seen in the
setting of extensive atherosclerotic degeneration of the
thoracic aorta with subsequent intimomedial disruption
and subsequent dissection of the hematoma either pro-
grade or antegrade (for varying distances). This produces
the typical radiographic feature of a crescent-like (or cir-
cumferential) ring in the aortic wall, which may or may not
be accompanied by an ulcer-like projection (or localized
dissection) on the imaging study.13 This hypothesis is in
contrast to those formulated many years ago that theorized
than an aortic IMH may either occur as a primary event in
hypertensive patients in whom there is spontaneous bleed-
ing from vasa vasorum into the media, or be caused by a
penetrating atherosclerotic ulcer.13
Spontaneous regression of an IMH of the descending
aorta has been documented with varying time courses.
Ohmi et al describe a patient who experienced two separate
episodes of IMH 10 months apart.1 In the first episode, the
hematoma involved the descending aorta and regressed
within 1 month. In the second episode, the hematoma
involved the ascending and transverse arch and resolved
within 24 hours. Both episodes were treated medically,
although in the latter case the patient was being prepared
for operative intervention because of the anatomic location
of the hematoma. In a second study, the same investigators
described the long-term follow-up of 94 patients with the
diagnosis of IMH from their institution. Type B IMH (n
53) was considered for medical treatment because only one
patient was initially treated surgically.2 Evangelista et al
noted that aortic IMH (thoracic or thoracoabdominal)
regressed without dilatation in 34% of their patients.5 More
recently, Sueyoshi et al have provided a more definitive
analysis of the predictive factors for patients with type B
IMH. Sueyoshi et al followed up 35 patients with type B
IMH over a 17-year period. They described two factors
that were associated with progression of the IMH, a maxi-
mum aortic diameter greater than 40 mm and an aortic
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diameter of 40 mm or more had a 30-fold higher incidence
of progression. Patients with an aortic diameter greater
than 1 cm had a nine-fold increase in progression.15 Our
patient had an aortic diameter of 31mm and 7mmof aortic
wall thickening. Interestingly, of the 20 patients without
evidence of progression of the IMH, 60% had regression of
the IMH and aortic diameter and thickness.15
Treatment of patients with IMH limited to the de-
scending aorta remains unsettled. In a review of 24 patients
from the Cleveland Clinic, 3 patients (13%) had symptoms
of acute ischemia, for which two patients required surgical
intervention. The third patient was not treated surgically
because the patient had presented with paraplegia. Of the
other 21 patients without acute complications, only one
patient had confirmed long-term resolution of the IMH.3
Tittle et al also showed that intramural hematomas have a
propensity to rupture, either at the initial presentation or
late.4
In a larger series of 50 patients followed up prospec-
tively, 15 patients had an observed regression of the IMH.5
These were patients who either were judged not to be
surgical candidates or did not have evidence of distal poor
perfusion. Nine of the patients in this series had an IMH
limited to the abdominal aorta; unfortunately, this article
does not mention the natural history of this subset of
patients. It is quite possible that if left alone, our patient
may have experienced regression of the IMH without sur-
gical intervention. However, his poor distal perfusion, as
evidenced by abdominal pain, increasing serum creatinine,
and progressive oliguria, probably would have led to signif-
icant morbidity and possible mortality.
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